Lilly: Saving Children With Global Insulin Donations

By David Kendall, M.D., VP medical affairs, Lilly Diabetes

Today’s guest blog comes from David Kendall, M.D., vice president for medical affairs, Lilly Diabetes.

The number of people living with diabetes is at an all-time high. More than 380 million people around the world have diabetes, and that number is expected to jump to nearly 600 million by the year 2035. These numbers, of course, include children—many from impoverished nations all over the world.

Aramark Launches Health and Wellness Educational Series for Families at Morristown Neighborhood House

Program kicks off with establishment of new urban gardens to provide fresh produce and inspire healthy lifestyles
Multimedia with summary

For many families living in metropolitan centers, access to fresh, healthy food is a daily struggle. Combined with a lack of understanding about good nutrition, it can lead to diet-related health problems like obesity and diabetes.  

Aramark is helping provide solutions to these issues, with a series of Healthy For Life™ health and wellness programs that will teach children and adults how to grow and prepare fresh, nutritious food.  

Novo Nordisk in the US – Teaming Up to Change Diabetes

Press Release

For the past 25 years, Novo Nordisk has been operating in the US with a focused commitment to improve the health of the millions of people living with diabetes. One of the key ingredients for the company’s success is collaboration. The latest issue of Novo Nordisk’s TBL Quarterly opens the playbook and shows how teamwork is helping make a difference for patients.

Freeport-McMoRan Receives John S. McCain Leadership Award

Press Release

July 14, 2015 /3BL Media/ - Freeport-McMoRan recently was honored with the prestigious John S. McCain Leadership Award by the Translational Genomics Research Institute in Phoenix for its support of TGen's research into melanoma, the most dangerous and aggressive kind of skin cancer.

Named after U.S. Sen. John McCain of Arizona, the annual award recognizes organizations whose leadership and dedication have made a significant impact in the fight against disease and helping patients worldwide.

New Study: 1.5 Billion Dollars Could be Saved by Reducing Complications for People with Diabetes in Russia

Press Release

April 9, 2015 /3BL Media/ - The challenge of diabetes continues to grow in Russia where 4 million people are diagnosed and even more are unaware of their condition. A new case study shows how Novo Nordisk together with partners is addressing this challenge and outlines the future potential for reducing the social and economic impact of diabetes in Russia.

Type 1 Diabetes - In Search of a Cure


Since Novo Nordisk was founded more than 90 years ago, the company has been committed to improving the lives of people with diabetes. Nothing would change the life of a child with type 1 diabetes more than a cure for this lifelong serious condition, but is a cure just a dream – or a potential reality?

How Diabetes Research Institute Foundation is Helping Solve the Diabetes Epidemic


For millions of children and adults living with diabetes today, a cure would mean the ability to restore natural insulin production and normalize blood sugar levels without imposing other risks.

Novo Nordisk Publishes 2014 Integrated Annual Report Emphasising Long-Term Thinking

2014 integrated annual report measures and reports performance on all three bottom lines.
Press Release

February 3, 2015 /3BL Media/ – Today Novo Nordisk published its 2014 Annual Report detailing the company’s performance. The report highlights the company’s progression towards long-term targets taking an integrated approach that accounts for financial, social and environmental performance.

Clinical Trials: More than safety and efficacy

The purpose of clinical research is to demonstrate the safety and efficacy of new medicine and the potential benefits that improve treatment. Novo Nordisk's new Blueprint for Change report shows that there is much more added value.
Press Release

January 27, 2015 /3BL Media/ – Clinical trials are a crucial part of the development process for human medicines. Without clinical trials pharmaceutical companies would be unable to document the efficacy, safety and optimal use of new medicines, limiting access to improved treatments.

Novo Nordisk Top Five Sustainability Stories of 2014

In 2014 Novo Nordisk celebrated 10 years as a company with a Triple Bottom Line approach to business. These are the stories from 2014 that caught people's eye.
Press Release

31 December, 2014, Bagsværd, Denmark /3BL Media/ - The readers have spoken! In 2014 Novo Nordisk celebrated 10 years as a company with a Triple Bottom Line approach to business. Throughout the year, Novo Nordisk shared stories and videos telling the actions and initiatives that demonstrate the company’s commitment to financial, environmental and social responsibility.

Here are the top five most read stores from Novo Nordisk’s sustainability communications.

1.The story of Novo Nordisk's Environmental Profit and Loss account


Subscribe to diabetes